Cargando…
Parameters for Irreversible Inactivation of Monoamine Oxidase
The irreversible inhibitors of monoamine oxidases (MAO) slow neurotransmitter metabolism in depression and neurodegenerative diseases. After oxidation by MAO, hydrazines, cyclopropylamines and propargylamines form a covalent adduct with the flavin cofactor. To assist the design of new compounds to c...
Autores principales: | Ramsay, Rona R., Basile, Livia, Maniquet, Antonin, Hagenow, Stefanie, Pappalardo, Matteo, Saija, Maria Chiara, Bryant, Sharon D., Albreht, Alen, Guccione, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763263/ https://www.ncbi.nlm.nih.gov/pubmed/33322203 http://dx.doi.org/10.3390/molecules25245908 |
Ejemplares similares
-
Evidence for a Cyanine Link Between Propargylamine Drugs and Monoamine Oxidase Clarifies the Inactivation Mechanism
por: Albreht, Alen, et al.
Publicado: (2018) -
Design, synthesis, molecular modelling and in vitro screening of monoamine oxidase inhibitory activities of novel quinazolyl hydrazine derivatives
por: Amer, Adel, et al.
Publicado: (2020) -
Ciproxifan, a histamine H(3) receptor antagonist, reversibly inhibits monoamine oxidase A and B
por: Hagenow, S., et al.
Publicado: (2017) -
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs
por: Ramsay, Rona R., et al.
Publicado: (2017) -
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015)